FEB 04, 2016 4:14 PM PST

Sharpin Protein Necessary for T Regulatory Cell Function

WRITTEN BY: Kara Marker
The body needs regulatory T cells (Tregs) on the sidelines of an immune attack, making sure tempers don’t run too hot and preventing the body’s lymphocytes from taking the body’s own cells. Because of this vital role, scientist strive to pinpoint the key mechanisms for Treg function and survival. The newest research calls on Sharpin, formally known as SHANK-Associated RH Domain Interactor, a protein involved linear polyubiquitination and associated with “inappropriate inflammation” (Gene Cards)
 
From the La Jolla Institute for Allergy and Immunology, Yun-Cai Liu, PhD, and his team set out to decipher definitively the relationship between Sharpin and Tregs. Their study was published in Nature Immunology earlier this month.
 
"Treg-based intervention has in fact been proposed as a novel therapeutic means to treat various inflammatory diseases, meaning that knowing how Treg function is regulated could speed development of effective treatments,” said study co-author Hyung-seung Jin.
 


To study the functionality of Tregs, the researchers observed mice that lacked any Sharpin protein. Not long after being born, the Sharpin knock-out mice developed skin lesions and internal inflammation, despite being free of any infections. The last clue was the low Treg cell count in all tissues, even in the thymus where all T lymphocytes develop. These outcomes strongly linked a lack of Sharpin to low numbers of Tregs, which resulted as expected in unnecessary inflammatory responses.
 
The team also replenished the Treg population in the knock-out mice by injecting healthy Tregs from normal mice who were born with Sharpin. They saw a clear reduction in inflammation severity.
 
Without the “cell survival mechanism” provided by Sharpin during Treg development, the lymphocytes die in the thymus. A single mutation in the genes coding for Sharpin could lead to autoimmune disease. Now scientists will know to check for Sharpin proteins in cases of autoimmune disease where Treg levels are low all over the body. If a lack of Sharpin ends up being the cause of disease, a treatment of healthy Tregs with ample Sharpin to keep them alive, similar to the replenishment done in this study, could potentially help people with autoimmune disease.
 
Also promising are the applications for cancer treatments made possible with this discovery. Scientists could carefully take advantage of Treg dependence on Sharpin for survival when fighting tumors in certain tissues. By limiting Sharpin production in certain tissues, killer lymphocytes like cytotoxic T cells could experience enhanced tumor recognition and attack more efficiently, behaviors which are usually heavily monitored and inhibited by Tregs.
 
 
Source: La Jolla Institute for Allergy and Immunology
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 29, 2019
Drug Discovery & Development
SEP 29, 2019
Researchers Can Now Reverse Skin Cancer
Ten years ago, just 5% of people with advanced melanoma (skin cancer) lived more than five years after being diagnosed. Now however, researchers from the I...
DEC 16, 2019
Drug Discovery & Development
DEC 16, 2019
Drug Targets Against The Nipah Virus
The Nipah virus, first identified in 1998 and is transmitted from pigs and bats, has resulted in a high mortality rate killing more than half of all infect...
DEC 21, 2019
Drug Discovery & Development
DEC 21, 2019
Improving Vaccines for Meningitis
Scientists at the University of Nottingham are seeking new ways to improve vaccine use in the protection against the bacterium, Neisseria meningitides that...
JAN 14, 2020
Clinical & Molecular DX
JAN 14, 2020
Can I eat this donut? A quick test for celiac disease.
Genetic testing revealed that our ancestors have been eating wheat, rye, spelt and barley for over 8,000 years. Today, gluten, a protein found within these...
JAN 07, 2020
Immunology
JAN 07, 2020
"Good" T Cells Can Go "Bad," But in the Case of Cancer, That's A Good Thing
T cells may be able to reach their full potential in the fight against cancer with a little nudge. In 2010, scientists first observed CD4+ T cells transiti...
FEB 13, 2020
Cancer
FEB 13, 2020
Can Ebola help treat glioblastomas?
You might want to sit down for this. New research published in the Journal of Virology has named a surprising new ally to brain tumors: Ebola. Yes, yo...
Loading Comments...